Genetic Signatures (ASX:GSS) EV-to-Revenue : 8.36 (As of May. 22, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Genetic Signatures EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Genetic Signatures's enterprise value is A$121.78 Mil. Genetic Signatures's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$14.56 Mil. Therefore, Genetic Signatures's EV-to-Revenue for today is 8.36.

The historical rank and industry rank for Genetic Signatures's EV-to-Revenue or its related term are showing as below:

ASX:GSS' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.05 Med: 14.75 Max: 46.26
Current: 8.36

During the past 9 years, the highest EV-to-Revenue of Genetic Signatures was 46.26. The lowest was 1.05. And the median was 14.75.

ASX:GSS's EV-to-Revenue is ranked worse than
78.48% of 223 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.24 vs ASX:GSS: 8.36

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-22), Genetic Signatures's stock price is A$0.76. Genetic Signatures's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.10. Therefore, Genetic Signatures's PS Ratio for today is 7.60.

Genetic Signatures EV-to-Revenue Historical Data

The historical data trend for Genetic Signatures's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Signatures EV-to-Revenue Chart

Genetic Signatures Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EV-to-Revenue

Get a 7-Day Free Trial

27.57

24.52

4.51

3.66

2.76

Genetic Signatures Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial													-	3.66	-	2.76	-

Competitive Comparison of Genetic Signatures's EV-to-Revenue

For the Diagnostics & Research subindustry, Genetic Signatures's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genetic Signatures's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Signatures's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Genetic Signatures's EV-to-Revenue falls into.

Genetic Signatures EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Genetic Signatures's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	121.780	/	14.559
	=	8.36

Genetic Signatures's current Enterprise Value is A$121.78 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genetic Signatures's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$14.56 Mil.

Genetic Signatures (ASX:GSS) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Genetic Signatures's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.76	/	0.1
	=	7.60

Genetic Signatures's share price for today is A$0.76.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was A$0.10.

Genetic Signatures EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Genetic Signatures's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Signatures (ASX:GSS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Signatures Ltd (ASX:GSS) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Eliza Street, Newtown, Sydney, NSW, AUS, 2042

Website

https://www.geneticsignatures.com

Genetic Signatures Ltd proprietary PCR solutions and automated workflows routinely screen for multiple infectious diseases in a single test. Rapid and accurate results facilitate improved patient management and healthcare outcomes. GSS continues to expand its global reach with direct representation in Australia, Europe, and the United States, and growing distribution partnerships. The company operates under one business segment which is the research and commercialisation of identifying individual genetic signatures to diagnose diseases and disabilities.